Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of GBP 174.11 billion. The enterprise value is 193.15 billion.
Market Cap | 174.11B |
Enterprise Value | 193.15B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
Earnings Date | Apr 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.24% |
Shares Change (QoQ) | -0.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.52B |
Valuation Ratios
The trailing PE ratio is 12.73.
PE Ratio | 12.73 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 26.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.48, with an EV/FCF ratio of 13.36.
EV / Earnings | 14.13 |
EV / Sales | 3.90 |
EV / EBITDA | 8.48 |
EV / EBIT | 10.05 |
EV / FCF | 13.36 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.83.
Current Ratio | 1.36 |
Quick Ratio | 0.87 |
Debt / Equity | 0.83 |
Debt / EBITDA | 1.30 |
Debt / FCF | 2.11 |
Interest Coverage | 19.58 |
Financial Efficiency
Return on equity (ROE) is 40.79% and return on invested capital (ROIC) is 19.62%.
Return on Equity (ROE) | 40.79% |
Return on Assets (ROA) | 13.90% |
Return on Invested Capital (ROIC) | 19.62% |
Return on Capital Employed (ROCE) | 28.06% |
Revenue Per Employee | 692,642 |
Profits Per Employee | 184,764 |
Employee Count | 75,000 |
Asset Turnover | 0.57 |
Inventory Turnover | 2.36 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.36% in the last 52 weeks. The beta is 0.71, so Merck & Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.71 |
52-Week Price Change | -17.36% |
50-Day Moving Average | 55.27 |
200-Day Moving Average | 59.00 |
Relative Strength Index (RSI) | 84.23 |
Average Volume (20 Days) | 287,913 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, Merck & Co. had revenue of GBP 51.26 billion and earned 13.67 billion in profits. Earnings per share was 5.38.
Revenue | 51.26B |
Gross Profit | 39.52B |
Operating Income | 19.88B |
Pretax Income | 15.92B |
Net Income | 13.67B |
EBITDA | 23.27B |
EBIT | 19.88B |
Earnings Per Share (EPS) | 5.38 |
Balance Sheet
The company has 10.93 billion in cash and 30.57 billion in debt, giving a net cash position of -19.63 billion.
Cash & Cash Equivalents | 10.93B |
Total Debt | 30.57B |
Net Cash | -19.63B |
Net Cash Per Share | n/a |
Equity (Book Value) | 37.04B |
Book Value Per Share | 14.64 |
Working Capital | 8.28B |
Cash Flow
In the last 12 months, operating cash flow was 17.15 billion and capital expenditures -2.69 billion, giving a free cash flow of 14.45 billion.
Operating Cash Flow | 17.15B |
Capital Expenditures | -2.69B |
Free Cash Flow | 14.45B |
FCF Per Share | n/a |
Margins
Gross margin is 77.09%, with operating and profit margins of 38.79% and 26.68%.
Gross Margin | 77.09% |
Operating Margin | 38.79% |
Pretax Margin | 31.07% |
Profit Margin | 26.68% |
EBITDA Margin | 45.40% |
EBIT Margin | 38.79% |
FCF Margin | 28.20% |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 45.80% |
Buyback Yield | 0.24% |
Shareholder Yield | 0.24% |
Earnings Yield | 7.85% |
FCF Yield | 8.30% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.65.
Altman Z-Score | 4.65 |
Piotroski F-Score | n/a |